Organic Letters
Letter
the C−F bond. Finally, target product 3ab is generated by
selective cross-coupling of radicals G and H.
To demonstrate the synthetic utility of the target products,
we carried out a gram-scale reaction of 1a and 2b under the
standard conditions and then removed the protecting group to
obtain a monofluoroalkenylation product of a secondary amine
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
(
67% yield for two steps, Scheme 7a). In addition, because
■
We are grateful to the National Key Research and Develop-
ment Program of China (2018YFD0200100) and the National
Natural Science Foundation of China (21732002, 21672117)
for generous financial support for our programs.
Scheme 7. Demonstration of Synthetic Utility
REFERENCES
■
(
1) (a) Hiyama, T. In Organofluorine Compounds: Chemistry and
Applications; Yamamoto, H., Ed.; Springer: Berlin, 2000. (b) Jeschke,
P. ChemBioChem 2004, 5, 570. (c) Pagliaro, M.; Ciriminna, R. J.
Mater. Chem. 2005, 15, 4981. (d) Thayer, A. M. Chem. Eng. News
2
006, 84, 15. (e) Kirk, K. L. J. Fluorine Chem. 2006, 127, 1013.
(
(
(
f) Begue, J.-P.; Bonnet-Delpon, D. J. Fluorine Chem. 2006, 127, 992.
g) Muller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881.
h) Hagmann, W. K. J. Med. Chem. 2008, 51, 4359. (i) Purser, S.;
́
́
Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37,
20. (j) Catalan, S.; Munoz, S. B.; Fustero, S. Chimia 2014, 68, 382.
2) (a) Babudri, F.; Farinola, G. M.; Naso, F.; Ragni, R. Chem.
3
(
́
Commun. 2007, 1003, 1003. (b) Babudri, F.; Cardone, A.; Farinola, G.
M.; Martinelli, C.; Mendichi, R.; Naso, F.; Striccoli, M. Eur. J. Org.
Chem. 2008, 2008, 1977.
most known medicinal agents contain one or more
heteroatoms (N, O, and/or S) and because the incorporation
of a monofluoroalkenyl group may improve the bioactivity, fat
solubility, and other properties of such agents, we used our
protocol to accomplish the late-stage functionalization of two
bioactive agents: precursor of tylocrebrine and linezolid
(3) (a) Asahina, Y.; Iwase, K.; Iinuma, F.; Hosaka, M.; Ishizaki, T. J.
Med. Chem. 2005, 48, 3194. (b) Edmondson, S. D.; Wei, L.; Xu, J.;
Shang, J.; Xu, S.; Pang, J.; Chaudhary, A.; Dean, D. C.; He, H.;
Leiting, B.; Lyons, K. A.; Patel, R. A.; Patel, S. B.; Scapin, G.; Wu, J.
K.; Beconi, M. G.; Thornberry, N. A.; Weber, A. E. Bioorg. Med. Chem.
Lett. 2008, 18, 2409. (c) Oishi, S.; Kamitani, H.; Kodera, Y.;
Watanabe, K.; Kobayashi, K.; Narumi, T.; Tomita, K.; Ohno, H.;
Naito, T.; Kodama, E.; Matsuoka, M.; Fujii, N. Org. Biomol. Chem.
(Scheme 7b). We were pleased to find that the desired
products could be obtained with excellent regioselectivity,
especially in the case of linezolid. That is, this reaction has the
potential to serve as a powerful method for late-stage
monofluoroalkenylation of medicinal agents containing several
heteroatoms.
2
009, 7, 2872. (d) Osada, S.; Sano, S.; Ueyama, M.; Chuman, Y.;
Kodama, H.; Sakaguchi, K. Bioorg. Med. Chem. 2010, 18, 605.
(4) (a) Van der Veken, P.; Senten, K.; Kertesz, I.; De Meester, I.;
Lambeir, A.-M.; Maes, M.-B.; Scharpe, S.; Haemers, A.; Augustyns, K.
̀
́
In summary, we have developed a protocol for a novel
J. Med. Chem. 2005, 48, 1768. (b) Niida, A.; Tomita, K.; Mizumoto,
M.; Tanigaki, H.; Terada, T.; Oishi, S.; Otaka, A.; Inui, K.; Fujii, N.
Org. Lett. 2006, 8, 613. (c) Couve-Bonnaire, S.; Cahard, D.;
Pannecoucke, X. Org. Biomol. Chem. 2007, 5, 1151.
3
monofluoroalkenylation reaction of inert α-C(sp )−H bonds
of a variety of heteroalkanes, including ethers and thioethers.
The resulting products, which have easily removable protecting
groups, show remarkable potential for further functionalization.
Mechanistic studies demonstrated that the reaction involves
cross-coupling between an α-aminoalkyl radical and a
monofluoroalkenyl radical. The mild conditions, high
selectivity, and broad substrate scope make this reaction an
advance in monofluoroalkenylation strategies.
(
5) (a) Lee, S. H.; Schwartz, J. J. Am. Chem. Soc. 1986, 108, 2445.
b) Chen, C.; Wilcoxen, K.; Strack, N.; McCarthy, J. R. Tetrahedron
Lett. 1999, 40, 827. (c) Ghosh, A. K.; Zajc, B. Org. Lett. 2006, 8, 1553.
d) Ghosh, A. K.; Zajc, B. Org. Lett. 2006, 8, 1553. (e) Landelle, G.;
(
(
Bergeron, M.; Turcotte-Savard, M.-O.; Paquin, J.-F. Chem. Soc. Rev.
2011, 40, 2867. (f) Yang, M.-H.; Matikonda, S. S.; Altman, R. A. Org.
Lett. 2013, 15, 3894. (g) Okoromoba, O. E.; Han, J.; Hammond, G.
B.; Xu, B. J. Am. Chem. Soc. 2014, 136, 14381. (h) Li, J.; Lefebvre, Q.;
Yang, H.; Zhao, Y.; Fu, H. Chem. Commun. 2017, 53, 10299.
ASSOCIATED CONTENT
Supporting Information
■
(
6) (a) Schneider, C.; Masi, D.; Couve-Bonnaire, S.; Pannecoucke,
X.; Hoarau, C. Angew. Chem., Int. Ed. 2013, 52, 3246; Angew. Chem.
013, 125, 3328. (b) Rousee, K.; Schneider, C.; Couve-Bonnaire, S.;
*
S
2
́
Pannecoucke, X.; Levacher, V.; Hoarau, C. Chem. - Eur. J. 2014, 20,
15000. (c) Tian, P.; Feng, C.; Loh, T.-P. Nat. Commun. 2015, 6, 7472.
(
7) Xie, J.; Yu, J.; Rudolph, M.; Rominger, F.; Hashmi, A. S. K.
Angew. Chem., Int. Ed. 2016, 55, 9416; Angew. Chem. 2016, 128, 9563.
8) Amines: Synthesis, Properties, and Applications; Lawrence, S. A.,
Ed.; Cambridge University: Cambridge, 2006.
9) (a) Nakata, T. Chem. Rev. 2005, 105, 4314. (b) Kang, E. J.; Lee,
General information, preparation of photocatalyst and
N-Boc amines, investigation of the key reaction
parameters, investigation of the mechamism, exper-
imental procedures and product characterization,
references, and NMR spectra (PDF)
(
(
E. Chem. Rev. 2005, 105, 4348. (c) Roughley, S. D.; Jordan, A. M. J.
Med. Chem. 2011, 54, 3451. (d) Taylor, R. D.; MacCoss, M.; Lawson,
A. D. G. J. Med. Chem. 2014, 57, 5845.
AUTHOR INFORMATION
■
(10) (a) Poirier, D.; Auger, S.; Merand, Y.; Simard, J.; Labrie, F. J.
Med. Chem. 1994, 37, 1115. (b) Greger, H.; Pacher, T.; Vajrodaya, S.;
Bacher, M.; Hofer, O. J. Nat. Prod. 2000, 63, 616. (c) Ke, Z.; Tan, C.
D
Org. Lett. XXXX, XXX, XXX−XXX